EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cryptococcosis in Colombia: Analysis of Data from Laboratory-Based Surveillance 2017–2024

Jairo Lizarazo iD, Clara Inés Agudelo iD, Patricia Escandón iD, Elizabeth Castañeda iD

Journal of Fungi · 14.01.2026 · 12 (1) · 67

DOI: 10.3390/jof12010067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 14.01.2026. Verfasst von Jairo Lizarazo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Medicina Interna, Hospital Universitario Erasmo Meoz, Cúcuta 540003, Norte de Santander, Colombia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 1997, a laboratory-based survey on cryptococcosis has been conducted in Colombia. We present the results for the period 2017–2024. A total of 891 surveys were received. The overall incidence was 0.22 cases per 100,000 people. Among those living with HIV, the incidence was 38, and among HIV-negative people, it was 0.08. Cryptococcosis demonstrated a higher prevalence among men than women (3.2:1). Among patients living with Human Immunodeficiency Virus (HIV), the condition primarily affected younger adults (26–40 years). In contrast, among HIV-negative people, it was mostly observed in older adults (≥60 years). HIV infection was the most significant risk factor (63%), but another cause of immunosuppression was identified in 21.2% cases. Neurocryptococcosis was the most common form of presentation (62.2%), followed by disseminated cryptococcosis (31.1%). The diagnosis was confirmed by culture in 99.4% of patients; the most important sample was cerebrospinal fluid (67.3%), followed by blood (35.4%). Cryptococcus neoformans was identified in 93.1% of cases, and Cryptococcus gatti in 6.9%. Predominant molecular patterns were VNI (92.4%) and VGII (45.3%). The epidemiology of cryptococcosis in Colombia is changing, with a progressive decrease in HIV coinfection and an increase in other immunosuppressive conditions in older people. This study highlights the importance of cryptococcosis in Colombia and the need to report it in order to improve knowledge and thereby promote the quality of diagnosis and the opportunity for more effective treatment.

Schlagwörter

Stichwörter der Autor:innen

ColombiaCryptococcal meningitisCryptococcus gattiCryptococcus neoformansHIVantifungal drug resistancecryptococcosisepidemiology

Autor:innen und Institutionen

  • Departamento de Medicina Interna, Hospital Universitario Erasmo Meoz, Cúcuta 540003, Norte de Santander, Colombia.
  • Grupo de Microbiología, Instituto Nacional de Salud, Bogotá 111321, Colombia.

ORCID-Profile: Jairo Lizarazo, Clara Inés Agudelo, Patricia Escandón, Elizabeth Castañeda

Zitieren

APA

Lizarazo, J., Agudelo, C. I., Escandón, P., & Castañeda, E. (2026). Cryptococcosis in Colombia: Analysis of Data from Laboratory-Based Surveillance 2017–2024. Journal of Fungi, 12(1), 67. https://doi.org/10.3390/jof12010067

Vancouver

Lizarazo J, Agudelo CI, Escandón P, Castañeda E. Cryptococcosis in Colombia: Analysis of Data from Laboratory-Based Surveillance 2017–2024. Journal of Fungi. 2026;12(1):67. doi:10.3390/jof12010067

BibTeX
@article{Lizarazo2026,
  author = {Lizarazo, Jairo and Agudelo, Clara Inés and Escandón, Patricia and Castañeda, Elizabeth},
  title = {Cryptococcosis in Colombia: Analysis of Data from Laboratory-Based Surveillance 2017–2024},
  journal = {Journal of Fungi},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {67},
  doi = {10.3390/jof12010067}
}
Kostenlos starten →